DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Verdeso (Desonide Topical) - Indications and Dosage

 
 



Indications and Usage

Verdeso Foam is indicated for the treatment of mild to moderate atopic dermatitis in patients 3 months of age and older.

Patients should be instructed to use Verdeso Foam for the minimum amount of time necessary to achieve the desired results because of the potential for Verdeso Foam to suppress the hypothalamic-pituitary-adrenal (HPA) axis (see Precautions). Treatment should not exceed 4 consecutive weeks.

Dosage and Administration

A thin layer of Verdeso Foam should be applied to the affected area(s) twice daily. Shake the can before use. Verdeso Foam should be dispensed by inverting the can (upright actuation will cause loss of the propellant which may affect product delivery). Dispense the smallest amount of foam necessary to adequately cover the affected area(s) with a thin layer.

The medication should not be dispensed directly on the face. Dispense in hands and gently massage into affected areas of the face until the medication disappears. For areas other than the face, the medication may be dispensed directly onto the affected area. Take care to avoid contact with the eyes or other mucous membranes.

Therapy should be discontinued when control is achieved. If no improvement is seen within 4 weeks, reassessment of diagnosis may be necessary. Treatment should not exceed 4 consecutive weeks.

Unless directed by a physician, Verdeso Foam should not be used with occlusive dressings.

How Supplied

Verdeso Foam is supplied in 100 g (NDC 63032-111-00) and 50 g (NDC 63032-111-50) aluminum cans.

Store at controlled room temperature 68–77°F (20–25°C).

Manufactured for:

Connetics Corporation

Palo Alto, CA 94304 USA

© 2006 Connetics Corporation

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2012